Evidence map›Paper›PMID 36723416›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023

Area-level Socioeconomic Disadvantage and Cancer Survival in Metropolitan Detroit.

Natalie G Snider, Theresa A Hastert, Mrudula Nair, Madhav Kc, Julie J Ruterbusch, Ann G Schwartz, Edward S Peters, Elena M Stoffel, Laura S Rozek, Kristen S Purrington

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Comparison of Neighborhood Socioeconomic Deprivation Measures and the Association with Survival among Black and White Women with Endometrial Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Natalie G SniderDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-8693-5354
Theresa A HastertDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-6251-6422
Mrudula NairDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-3453-9560
Madhav KcDepartment of Internal Medicine, Yale School of Medicine, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, Connecticut.ORCID 0000-0002-4659-4348
Julie J RuterbuschDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-8089-7409
Ann G SchwartzDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-9525-1157
Edward S PetersDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska.ORCID 0000-0003-4928-6532
Elena M StoffelDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan.ORCID 0000-0002-5637-3418
Laura S RozekDepartment of Oncology, Georgetown University School of Medicine, Washington, District of Columbia.ORCID 0000-0001-6731-7000
Kristen S PurringtonDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-5710-1692
Wayne State University · USGeorgetown University · USMichigan Medicine · USNebraska Medical Center · USYale Cancer Center · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohortR01CA259420 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kristen S. Purrington, LAURA ROZEK · 2021 to 2026
$3.4M
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trialR01CA287257 · NCI · UNIVERSITY OF CHICAGO · PI Fay Kastrinos, Sonia Kupfer · 2024 to 2026
$3.4M
CCR NIH HHS HHSN261201300011CNCI NIH HHS P30 CA022453NCI NIH HHS R01 CA259420NCI NIH HHS R01 CA287257
6 · The paper itself

Abstract

backgroundRacial segregation is linked to poorer neighborhood quality and adverse health conditions among minorities, including worse cancer outcomes. We evaluated relationships between race, neighborhood social disadvantage, and cancer survival.

methodsWe calculated overall and cancer-specific survival for 11,367 non-Hispanic Black (NHB) and 29,481 non-Hispanic White (NHW) individuals with breast, colorectal, lung, or prostate cancer using data from the Metropolitan Detroit Cancer Surveillance System. The area deprivation index (ADI) was used to measure social disadvantage at the census block group level, where higher ADI is associated with poorer neighborhood factors. Associations between ADI and survival were estimated using Cox proportional hazards mixed-effects models accounting for geographic grouping and adjusting for demographic and clinical factors.

resultsIncreasing ADI quintile was associated with increased overall mortality for all four cancer sites in multivariable-adjusted models. Stratified by race, these associations remained among breast (NHW: HR = 1.16, P < 0.0001; NHB: HR = 1.20, P < 0.0001), colorectal (NHW: HR = 1.11, P < 0.0001; NHB: HR = 1.09, P = 0.00378), prostate (NHW: HR = 1.18, P < 0.0001; NHB: HR = 1.18, P < 0.0001), and lung cancers (NHW: HR = 1.06, P < 0.0001; NHB: HR = 1.07, P = 0.00177). Cancer-specific mortality estimates were similar to overall mortality. Adjustment for ADI substantially attenuated the effects of race on mortality for breast [overall proportion attenuated (OPA) = 47%, P < 0.0001; cancer-specific proportion attenuated (CSPA) = 37%, P < 0.0001] prostate cancer (OPA = 51%, P < 0.0001; CSPA = 56%, P < 0.0001), and colorectal cancer (OPA = 69%, P = 0.032; CSPA = 36%, P = 0.018).

conclusionsArea-level socioeconomic disadvantage is related to cancer mortality in a racially diverse population, impacting racial differences in cancer mortality. IMPACT: Understanding the role of neighborhood quality in cancer survivorship could improve community-based intervention practices.

Indexed as

NeoplasmsSocioeconomic Disparities in HealthEthnicityHumansSocioeconomic Factors

Identifiers

PMID36723416
PMCPMC10071652
OpenAlexW4318755294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.